Characterisation of autoantibodies to peripheral myelin protein 22 in patients with hereditary and acquired neuropathies
- 1 May 2000
- journal article
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 104 (2) , 155-163
- https://doi.org/10.1016/s0165-5728(99)00250-7
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Influence of elevated expression of rat wild-type PMP22 and its mutant PMP22 Trembler on cell growth of NIH3T3 fibroblastsCell and tissue research, 1997
- Rapid Communication: Human Peripheral Myelin Protein‐22 Carries the L2/HNK‐1 Carbohydrate Adhesion EpitopeJournal of Neurochemistry, 1993
- Charcot–Marie–Tooth neuropathy type 1B is associated with mutations of the myelin P0 geneNature Genetics, 1993
- Immunoreactivity of PMP‐22, P0, and other 19 to 28 kDa glycoprotens in peripheral nerve myelin of mammals and fish with HNK1 and related antibodiesJournal of Neuroscience Research, 1993
- Miller Fisher syndrome is associated with serum antibodies to GQ1b ganglioside.Journal of Neurology, Neurosurgery & Psychiatry, 1993
- Peripheral myelin protein–22 gene maps in the duplication in chromosome 17p11.2 associated with Charcot–Marie–Tooth 1ANature Genetics, 1992
- The peripheral myelin protein gene PMP–22 is contained within the Charcot–Marie–Tooth disease type 1A duplicationNature Genetics, 1992
- The gene for the peripheral myelin protein PMP–22 is a candidate for Charcot–Marie–Tooth disease type 1ANature Genetics, 1992
- Gene dosage is a mechanism for Charcot-Marie-Tooth disease type 1ANature Genetics, 1992
- Duplication in chromosome 17p11.2 in Charcot-Marie-Tooth neuropathy type 1a (CMT 1a)Neuromuscular Disorders, 1991